Long COVID: a review and proposed visualization of the complexity of long COVID
R Perumal, L Shunmugam, K Naidoo… - Frontiers in …, 2023 - frontiersin.org
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …
Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
H Hernández-Parra, OD Reyes-Hernández… - Frontiers in Cellular …, 2023 - frontiersin.org
Diverse neurological symptoms have been reported in patients with SARS-CoV-2 disease
(COVID-19), including stroke, ataxia, meningitis, encephalitis, and cognitive impairment …
(COVID-19), including stroke, ataxia, meningitis, encephalitis, and cognitive impairment …
COVID‐19 induces neuroinflammation and suppresses peroxisomes in the brain
A Roczkowsky, D Limonta, JP Fernandes… - Annals of …, 2023 - Wiley Online Library
Objective Peroxisome injury occurs in the central nervous system (CNS) during multiple
virus infections that result in neurological disabilities. We investigated host neuroimmune …
virus infections that result in neurological disabilities. We investigated host neuroimmune …
Human brain organoids as models for central nervous system viral infection
Pathogenesis of viral infections of the central nervous system (CNS) is poorly understood,
and this is partly due to the limitations of currently used preclinical models. Brain organoid …
and this is partly due to the limitations of currently used preclinical models. Brain organoid …
COVID-19 as a Risk Factor for Alzheimer's Disease
M Golzari-Sorkheh, DF Weaver… - Journal of Alzheimer's …, 2023 - content.iospress.com
Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …
[HTML][HTML] Neuropsychiatric sequelae of long COVID-19: pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA
Background As the coronavirus disease 2019 (COVID-19) pandemic continues, there has
been a growing interest in the chronic sequelae of COVID-19. Neuropsychiatric symptoms …
been a growing interest in the chronic sequelae of COVID-19. Neuropsychiatric symptoms …
SARS-CoV-2 and the nervous system: current perspectives
A Pattanaik, S Bhandarkar B, L Lodha, S Marate - Archives of Virology, 2023 - Springer
SARS-CoV-2 infection frequently causes neurological impairment in both adults and
children. Recent publications have described significant aspects of the viral pathophysiology …
children. Recent publications have described significant aspects of the viral pathophysiology …
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations
Background To assess whether SARS-CoV-2 infection may affect the central nervous
system, specifically neurons and glia cells, even without clinical neurological involvement …
system, specifically neurons and glia cells, even without clinical neurological involvement …
[HTML][HTML] Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms
AM Plummer, YL Matos, HC Lin, SG Ryman… - Frontiers in …, 2023 - frontiersin.org
Approximately one third of non-hospitalized coronavirus disease of 2019 (COVID-19)
patients report chronic symptoms after recovering from the acute stage of severe acute …
patients report chronic symptoms after recovering from the acute stage of severe acute …
Rationale for Nicotinamide Adenine Dinucleotide (NAD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome
T Block, J Kuo - Clinical Pathology, 2022 - journals.sagepub.com
Many acute COVID-19 convalescents experience a persistent sequelae of infection, called
post-acute COVID-19 syndrome (PACS). With incidence ranging between 31% and 69 …
post-acute COVID-19 syndrome (PACS). With incidence ranging between 31% and 69 …